Italia - Kiitaliano - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - proguanil, associazioni - proguanil, associazioni

Italia - Kiitaliano - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - lamivudina - lamivudina

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

laboratoire hra pharma - ulipristal - contraccezione, postcoital - ormoni sessuali e modulatori del sistema genitale, , contraccettivi di emergenza - contraccezione d'emergenza entro 120 ore (cinque giorni) di rapporti sessuali non protetti o fallimento contraccettivo.

Italia - Kiitaliano - AIFA (Agenzia Italiana del Farmaco)

sun pharmaceutical industries (europe) b.v. - rivaroxaban - rivaroxaban

Italia - Kiitaliano - myHealthbox

krka farmaceutici milano - mirtazapina - compresse rivestite con film - 30mg - altri antidepressivi - trattamento di episodi di depressione maggiore.

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplasie al seno - agenti antineoplastici - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - agenti antineoplastici - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - neoplasie prostatiche - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Umoja wa Ulaya - Kiitaliano - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - follitropina delta - anovulazione - ormoni sessuali e modulatori del sistema genitale, - stimolazione ovarica controllata per lo sviluppo di follicoli multipli in donne sottoposte a tecnologie di riproduzione assistita (art) come un ciclo di fecondazione in vitro (ivf) o iniezione intracitoplasmatica di spermatozoi (icsi).

Italia - Kiitaliano - myHealthbox

teva italia - levonorgestrel, etinilestradiolo - compresse rivestite con film - compresse rosa 150/30 microgrammi + compresse bianche 10 microgrammi - ormoni sessuali e modulatori dell'apparato genitale, contraccettivi orali per uso sistemico, progestinici ed estrogeni - contraccezione orale